5 completed, 1 not yet recruiting, 1 terminated. 7 Phase 2, 3 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 5, Not yet recruiting 1, Terminated 1 |
| Phase 3 | 3 | Completed 3 |
| Phase 1 | 1 | Not yet recruiting 1 |
Follow Pain, Procedural: new trials by email Literature Review of Pain, Procedural trials Research Report on Pain, Procedural
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fentanyl Intranasal for Retinopathy of Prematurity Screening in Preterm Infants Fentanyl Citrate (Intranasal), Normal Saline (Placebo, Intranasal) - Neonatal Pain, Retinopathy of Prematurity (ROP) | Phase 1 / Phase 2 | Not yet recruiting | Marsha Campbell-Yeo | 58 | 2026-09-09 | 2026-06-30 |
| Lavender Aromatherapy to Decrease Anxiety/Pain Perception During Office Hysteroscopy Lavandula angustifolia, Aura Cacia, Placebo - Anxiety, Pain, Procedural | Phase 2 | Terminated | University of Florida | 22 | 2024-06-01 | 2026-06-10 |
| Pediatric Pain Optimization After Tonsillectomy Fentanyl/Hydromorphone, Methadone - Obstructive Sleep Apnea, Tonsillitis | Phase 2 | Completed | Duke University | 66 | 2022-04-08 | 2024-10-17 |
| VR for Burn Dressing Changes at Home VR-PAT - Burns, Acute Pain | Phase 2 / Phase 3 | Completed | Nationwide Children's Hospital | 36 | 2019-09-05 | 2024-04-30 |
| Safety of Intranasal Fentanyl (PecFent®) in the Treatment of Procedural Pain in the Elderly intranasal fentanyl - Pain Due to Certain Specified Procedures | Phase 2 / Phase 3 | Completed | University Hospital, Grenoble | 58 | 2014-12-08 | 2018-05-08 |
| A Test of the Effectiveness of a Device and Distraction for Pediatric Immunization Pain Device: Buzzy, Buzzy: sham device - Procedural Pain | Phase 2 / Phase 3 | Completed | MMJ Labs LLC | 345 | 2010-04-01 | 2011-06-22 |
| Study of ALGRX 3268 for Needlestick Pain in Children ALGRX 3268 - Pain | Phase 2 | Completed | AlgoRx Pharmaceuticals | 260 | 2004-05-01 | 2005-10-10 |
Pain (3) · Acute Pain (1) · Agnosia (1) · Anxiety Disorders (1) · Burns (1) · Premature Birth (1) · Retinopathy of Prematurity (1) · Sleep Apnea, Obstructive (1) · Tonsillitis (1)
Neurologic Manifestations (7) · Pathological Conditions, Signs and Symptoms (7) · Signs and Symptoms (7) · Pain (4) · Nervous System Diseases (2) · Apnea (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Dyssomnias (1) · Eye Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Infant, Newborn, Diseases (1) · Infant, Premature, Diseases (1) · Infections (1) · Mental Disorders (1) · Neurobehavioral Manifestations (1)
Fentanyl (2) · Hydromorphone (1) · Methadone (1) · Saline Solution (1)
AlgoRx Pharmaceuticals (1) · Duke University (1) · MMJ Labs LLC (1) · Marsha Campbell-Yeo (1) · Nationwide Children's Hospital (1) · University Hospital, Grenoble (1) · University of Florida (1)
United States (4) · Canada (1) · France (1)
Henry Xiang, MD, MPH, PhD (1) · Lisa M Einhorn, MD (1) · Tiffani-Amber Miller, MD (1) · William Zempsky, MD (1)
PMID 35982492, PMID 38669011, PMID 42458331
R44HD056647 (1)